We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.03 | -1.80% | 1.641 | 1.62 | 1.66 | 1.642 | 1.62 | 1.64 | 5,990,463 | 16:35:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.63 | 18.5M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/4/2024 11:39 | By tempted back in below 1.4 | trying2trade | |
12/4/2024 09:59 | biodefence still rumbling. This issue may be on going so this gives Dr Sandler the opportunity to implement a alternative supplier ? | dreamtwister | |
10/4/2024 14:28 | Doing well innit | albert35911 | |
09/4/2024 15:19 | interesting link below, custom & off the shelf car-t manufacturing pro`s & cons ? hemogenyx have chosen to go down the custom route, | dreamtwister | |
08/4/2024 20:54 | FDA accepts Shorla’s oral liquid leukemia drug NDA SH-201 is an oral liquid drug, making the treatment accessible to patients who may struggle with taking tablets or other dosage forms. It slows or stops the growth of certain forms of leukemia, including chronic myeloid leukemia and acute lymphoblastic leukemia. The blood science is becoming more accessible & cost effective.... Below the link gives a insight to the Car-t science. | dreamtwister | |
08/4/2024 09:05 | well the cd38 therapy has been approved, Dr Sandler has now to bring cd19 to the clinical trials. | dreamtwister | |
07/4/2024 19:54 | hxxps://www.biospace Hemo next? bankruptcies skyrocket in biotech !! WHO OWNS HEMO CASINO SHARES !!? | marcus80 | |
07/4/2024 18:12 | Great news ! FDA allows expanded use of cell therapies for blood cancer The drugs from Johnson & Johnson and Bristol Myers Squibb can be used to treat patients in the earlier stages of a type of blood cancer. | dreamtwister | |
05/4/2024 11:53 | U.S. Application No. 17/133,448 Title: METHOD OF ELIMINATING HEMATOPOIETIC STEM CELLS/HEMATOPOIETIC PROGENITORS (HSC/HP) IN A PATIENT USING BI-SPECIFIC ANTIBODIES Applicant: HEMOGENYX LLC Inventor: Vladislav Sandler Issued as U.S. Patent No. 11,945,866 on April 2, 2024. | ashleyjv | |
05/4/2024 11:22 | End of year results due 28/29th | dreamtwister | |
05/4/2024 11:15 | Any reason why ? | john henry | |
05/4/2024 09:38 | i can for-see a Drug shortage leading to costs rising due to the USA V CHINA Biodefence Should congress pass the Legislation & it becomes Mandatory then i trust Dr Sandler has a plan B. " The Consumer is Not the Customer ! | dreamtwister | |
05/4/2024 09:13 | https://www.londonst | blackhorse23 | |
05/4/2024 08:30 | No it appears to be that ashleyjv is spot on as it is now April [and the last day of the current tax year with the new tax year starting on Monday] | apotheki | |
04/4/2024 13:31 | the security issues !The Fda have lifted the clinical hold but i find misleading as Wuxi are the providers of the Lentivirus ? | dreamtwister | |
02/4/2024 12:54 | reading the pharma rags this morning it brings sadness to see, Redx's plans mirror those of C4X Discovery, which is also exiting AIM dissatisfied with its lack of access to growth capital. I knowledge that Hemogenyx are listed on the Main Market & the option to downgrade to the Aim market which would give Hemogenyx Flexibility to raise further Equity or eclipse Redx/C4x with taking the science private before a Hostile t/o with the present sultry share price or Visa-versa spin off one of the other scientific platforms ! in the event of Privatization Shareholder will receive a dividend should some financial Muscle shows interest ? | dreamtwister | |
28/3/2024 15:13 | Tax Year for Private Investors? Hemo's was in December and hopefully the results are due to be next Month (April) | ashleyjv | |
28/3/2024 15:05 | End of the trading month and quarter today - then just 4 trading days to the end of this tax year next week. Reckon that ahead of the new tax year that next week could be better for small caps including of course Hemogenyx Pharmaceuticals | apotheki | |
28/3/2024 10:01 | Tannedgirl…it& | albert35911 | |
28/3/2024 10:00 | Tannedgirl… | albert35911 | |
27/3/2024 21:59 | 24hr manufacturing ! yet to be tested in humans but proven in mouse models. The on going bio-security. Made in china ! Sounds plausible as they IPO the Data. | dreamtwister | |
27/3/2024 14:13 | Not many suckers buying today,they must be getting wise. | albert35911 | |
26/3/2024 13:44 | Will Hemo spend Easter at 1.80p + | steveberyl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions